Historical Stock Price
| Home |
| Free Dividend Report |
| Stock Splits Calendar |
| AIM Historical Stock Prices |
| Preferred Stock Newsletter |
| Top Option Ideas |
| Stock Message Boards |
AIM ImmunoTech (AIM) has the following price history information. Looking back at AIM historical stock prices for the last five trading days, on January 13, 2022, AIM opened at $0.93, traded as high as $0.95 and as low as $0.89, and closed at $0.91. Trading volume was a total of 282.40K shares. On January 14, 2022, AIM opened at $0.91, traded as high as $0.92 and as low as $0.88, and closed at $0.89. Trading volume was a total of 123.50K shares. On January 18, 2022, AIM opened at $0.89, traded as high as $0.90 and as low as $0.86, and closed at $0.88. Trading volume was a total of 131.40K shares. On January 19, 2022, AIM opened at $0.86, traded as high as $0.89 and as low as $0.78, and closed at $0.80. Trading volume was a total of 542.60K shares. On January 20, 2022, AIM opened at $0.81, traded as high as $0.86 and as low as $0.81, and closed at $0.82. Trading volume was a total of 230.30K shares.
AIM Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AIM ImmunoTech shares, starting with a $10,000 purchase of AIM, and working forward through the historical stock price information to today.
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 01/24/2012 | |
| End date: | 01/20/2022 | |
| Start price/share: | $0.24 | |
| End price/share: | $0.82 | |
| Dividends collected/share: | $0.00 | |
| Total return: | 241.67% | |
| Average Annual Total Return: | 13.08% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $34,175.25 | |
| Years: | 10.00 | |
 | |||||
| AIM Historical Price Range | |||||
| Date | Open | High | Low | Close | Volume |
| 01/13/2022 | $0.93 | $0.95 | $0.89 | $0.91 | 282.40K |
| 01/14/2022 | $0.91 | $0.92 | $0.88 | $0.89 | 123.50K |
| 01/18/2022 | $0.89 | $0.90 | $0.86 | $0.88 | 131.40K |
| 01/19/2022 | $0.86 | $0.89 | $0.78 | $0.80 | 542.60K |
| 01/20/2022 | $0.81 | $0.86 | $0.81 | $0.82 | 230.30K |
|
| About AIM ImmunoTech |
| AIM ImmunoTech is an immuno-pharma company that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Co.'s primary pharmaceutical product platform consists of Ampligen® and Alferon N Injection®. Ampligen® is approved for sale in Argentina for severe Chronic Fatigue Syndrome (CFS) and is an experimental drug in the U.S. undergoing clinical development for the treatment of certain cancers and myalgic encephalomyelitis/CFS. Alferon® is a natural-source, multi-species alpha interferon for the intralesional treatment of refractory or recurring external genital warts in patients 18 years of age or older. |
| AIM Historical Closing Prices | |
| Date | Close |
| 01/13/2022 | $0.91 |
| 01/14/2022 | $0.89 |
| 01/18/2022 | $0.88 |
| 01/19/2022 | $0.80 |
| 01/20/2022 | $0.82 |
| Services Historical Prices |
| AIM is categorized under the Services sector; below are some other companies in the same sector:
ALCS Historical Stock Prices
|
Free AIM Email Alerts:
